Chip-seq of YAP1 binding signals in mouse liver cancer cells under irradation treatment

To enhance the efficacy of radio-immunotherapy and sensitize tumors to treatment, we employed an in vivo screening method to identify key metabolic enzymes involved in therapy response. We discovered that PHGDH, a limited metabolic enzyme involved in de novo serine synthesis, targets the LATS1/2 kinase and activates the YAP1 nuclear translocation and its noncanonical signal transduction under irradiation treatment, thereby promoting tumor tolerance.The goal of the study is to profile the YAP1 binding signals in the mouse liver cancer cells under irradiation treatment.